SCHEMBL24313660

SCHEMBL24313660

CCOc1cc(F)ccc1[S+]([O-])NC(=O)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 9/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CYP2C9 P11712 1/20 0.35
ADRA2B P18089 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
CYP2C19 P33261 1/20 0.35
DRD3 P35462 1/20 0.35
HTR2B P41595 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
MCHR1 Q99705 10/20 0.34
MAPT P10636 2/20 0.33
MRGPRX1 Q96LB2 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314235 0.93 KCNH2 (0.36) KCNH2KMT2AMEN1LMNACYP1A2
SCHEMBL24313754 0.92 MEN1 (0.36) KCNH2KMT2AMEN1LMNACYP1A2
SCHEMBL24313761 0.90 MEN1 (0.32) KCNH2KMT2AMEN1LMNACYP1A2
SCHEMBL24313966 0.85 UGCG (0.35) KCNH2LMNAMCHR1MRGPRX1ALDH1A1
SCHEMBL24313682 0.85 ALDH1A1 (0.34) KCNH2KMT2AMEN1LMNACYP1A2
SCHEMBL24313977 0.85 CYP1A2 (0.37) KCNH2KMT2AMEN1CYP1A2CYP3A4
SCHEMBL24314298 0.84 MEN1 (0.33) KCNH2KMT2AMEN1MCHR1MAPT
SCHEMBL24314303 0.84 MEN1 (0.35) KCNH2KMT2AMEN1LMNACYP1A2
SCHEMBL24314310 0.84 SSTR5 (0.34) KCNH2KMT2AMEN1LMNACYP1A2
SCHEMBL24313750 0.83 KAT2B (0.33) KCNH2MCHR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed